Abnormal Amount of Human DNA found in Vaccines Analyzed by Corvelva
Two years ago, researchers at Corvelva, an independent Italian research association, began to analyze the contents of vaccine vials on the market, and what they found is very concerning. They announced recently that the results of their first tests have now passed peer review and have been published. Their announcement can be found HERE.
“. . . the first major issue that we found ourselves having to investigate was the abnormal amount of human DNA found in the vaccines analyzed.”
In that first investigation, they examined the contents of GSK’s measles-mumps-rubella-varicella, Priorix, which is not yet used in the United States, but may soon be if Merck loses its U.S. license to the MMR II as a result of the federal fraud case against them. Merck’s MMR II and MMRV also have components cultured in fetal cells, and thus are also contaminated with fetal DNA, as are several other vaccines now in use in the United States, in amounts that are not yet known, and may vary per vial.
Corvelva explains:
“The contaminating fetal DNA present in all the samples analyzed in variable quantities (therefore uncontrolled) is up to 300 times higher than the limit set by the EMA for carcinogenic DNA (10 ng / dose, corresponding to the DNA contained in about 1000 cancer cells, obtained on the basis of a statistical calculation, while the precautionary limit is 100 pg / dose) limit which must necessarily be applied also to the fetal DNA that inevitably contaminates the Priorix Tetra.”
And:
“It follows that this vaccine must be considered defective and potentially dangerous for human health, in particular of the pediatric population much more vulnerable to genetic and autoimmune damage due to immaturity in the shelter systems.”
Dr. Theresa Deisher, who discovered adult stem cells, wrote to legislators in 2019 with evidence of her concerns regarding fetal DNA contamination of vaccines. See the Open Letter.
Corvelva’s other investigations into the contents of vaccine vials on the market found:
- contaminating genetic material
- missing antigens (those that the vaccine was supposed to protect against)
- APDB (illegal amphetamine) in Gardasil 9
- human and mouse DNA
- Adventitious viruses (L1 fragment of the HPV virus of double-chain DNA; Phages; Molluscum contagiosum virus)
- Retrovirus: Murine leukemia virus; Saccharomyces
- Human endogenous retrovirus K;
- Avian leukosis virus;
- HERV-H / env62.
More information on these investigations can be found on Corvelva’s Vaccinegate Summary Page.
Together with other investigations into the actual vial-content of vaccines on the market which found troubling contaminants and retroviruses, Corvelva’s investigations reveal the lack of quality oversight at many levels of vaccine production and distribution. This problem is not isolated to vaccines, but sadly impacts many biologicals and pharmaceuticals, as evidenced by the number of warning letters and recalls issued by the FDA. The vast majority of products are never closely examined at the level performed by Corvelva. The issues emerging by these independent investigations into vaccine products potentially impacts the health of every child on earth, and for that reason, these problems must immediately be addressed.
Links:
https://www.corvelva.it/en/speciale-corvelva/vaccinegate/prima-pubblicazione-peer-review-sui-vaccini-mprv-priorix-tetra-e-mmrvaxpro.html
